Ibrahim El‐Serafi

800 total citations
31 papers, 593 citations indexed

About

Ibrahim El‐Serafi is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Ibrahim El‐Serafi has authored 31 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Ibrahim El‐Serafi's work include Pharmacogenetics and Drug Metabolism (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Carcinogens and Genotoxicity Assessment (4 papers). Ibrahim El‐Serafi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Carcinogens and Genotoxicity Assessment (4 papers). Ibrahim El‐Serafi collaborates with scholars based in Sweden, United Arab Emirates and Egypt. Ibrahim El‐Serafi's co-authors include Moustapha Hassan, Manuchehr Abedi‐Valugerdi, Heba Asem, Fei Ye, Jonas Mattsson, Mamoun Muhammed, Khalid M. Abu–Salah, Åsa Barrefelt, Ahmed T. El‐Serafi and Salman Alrokayan and has published in prestigious journals such as Blood, PLoS ONE and Biomaterials.

In The Last Decade

Ibrahim El‐Serafi

29 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ibrahim El‐Serafi Sweden 12 178 158 150 147 68 31 593
Qianqian Wang China 14 220 1.2× 128 0.8× 359 2.4× 104 0.7× 91 1.3× 29 896
Christian A. Fernandez United States 16 110 0.6× 82 0.5× 318 2.1× 131 0.9× 86 1.3× 33 725
Chung Hee Sonn South Korea 13 85 0.5× 165 1.0× 233 1.6× 98 0.7× 149 2.2× 20 602
Zhengsheng Liu China 20 148 0.8× 125 0.8× 274 1.8× 107 0.7× 74 1.1× 49 1.1k
Jeong Uk Choi South Korea 20 220 1.2× 232 1.5× 383 2.6× 259 1.8× 109 1.6× 57 967
Ping Cai China 12 299 1.7× 85 0.5× 196 1.3× 172 1.2× 77 1.1× 32 716
Wenqi Jiang China 14 130 0.7× 183 1.2× 395 2.6× 70 0.5× 97 1.4× 22 796
Kuo‐Hsiang Chuang Taiwan 14 126 0.7× 79 0.5× 321 2.1× 136 0.9× 72 1.1× 32 605
Meng Du China 19 299 1.7× 142 0.9× 371 2.5× 124 0.8× 78 1.1× 52 924

Countries citing papers authored by Ibrahim El‐Serafi

Since Specialization
Citations

This map shows the geographic impact of Ibrahim El‐Serafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim El‐Serafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim El‐Serafi more than expected).

Fields of papers citing papers by Ibrahim El‐Serafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim El‐Serafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim El‐Serafi. The network helps show where Ibrahim El‐Serafi may publish in the future.

Co-authorship network of co-authors of Ibrahim El‐Serafi

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim El‐Serafi. A scholar is included among the top collaborators of Ibrahim El‐Serafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim El‐Serafi. Ibrahim El‐Serafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Serafi, Ibrahim, Sofia Berglund, Alina Codita, et al.. (2025). Mechanisms underlying seizures and hypothermia during busulphan administration. Bone Marrow Transplantation. 60(8). 1120–1128.
2.
El‐Serafi, Ibrahim, et al.. (2024). Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells. Cancer Immunology Immunotherapy. 73(9). 163–163. 3 indexed citations
3.
El‐Serafi, Ibrahim, et al.. (2024). Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics. Advances in Pharmacological and Pharmaceutical Sciences. 2024(1). 4862706–4862706. 8 indexed citations
4.
El‐Serafi, Ibrahim, Sandra Oerther, Ying Zhao, & Moustapha Hassan. (2022). The Role of Cytochrome P450 2J2 in Cancer: Cell Protector, Therapeutic Target, or Prognostic Marker?. 6(3). 1–4. 3 indexed citations
5.
Elmasry, Moustafa, et al.. (2022). Biomaterials as a Vital Frontier for Stem Cell-Based Tissue Regeneration. Frontiers in Cell and Developmental Biology. 10. 713934–713934. 21 indexed citations
6.
El‐Serafi, Ibrahim, et al.. (2022). Non-additive effect of the DNA methylation inhibitor, 5-Aza-dC, and glass as a culture surface on osteogenic differentiation. Heliyon. 8(12). e12433–e12433. 8 indexed citations
7.
El‐Serafi, Ahmed T., Ibrahim El‐Serafi, Ingrid Steinvall, Folke Sjöberg, & Moustafa Elmasry. (2022). A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective. International Journal of Molecular Sciences. 23(14). 7934–7934. 23 indexed citations
8.
Schoutrop, Esther, Ibrahim El‐Serafi, Thomas Poiret, et al.. (2021). Mesothelin-Specific CAR T Cells Target Ovarian Cancer. Cancer Research. 81(11). 3022–3035. 76 indexed citations
9.
El‐Serafi, Ibrahim, Mats Remberger, Ahmed T. El‐Serafi, et al.. (2018). The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation. Scientific Reports. 8(1). 8293–8293. 11 indexed citations
10.
Remberger, Mats, Johan Törlén, Ibrahim El‐Serafi, et al.. (2017). Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation. International Journal of Hematology. 106(4). 471–475. 8 indexed citations
11.
El‐Serafi, Ibrahim, Ylva Terelius, Manuchehr Abedi‐Valugerdi, et al.. (2017). Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway. PLoS ONE. 12(11). e0187294–e0187294. 16 indexed citations
12.
Asem, Heba, Ying Zhao, Fei Ye, et al.. (2016). Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging. Journal of Nanobiotechnology. 14(1). 82–82. 26 indexed citations
13.
El‐Serafi, Ibrahim, Mohammad M. Fares, Manuchehr Abedi‐Valugerdi, et al.. (2015). Cytochrome P450 2J2, a new key enzyme in cyclophosphamide bioactivation and a potential biomarker for hematological malignancies. The Pharmacogenomics Journal. 15(5). 405–413. 24 indexed citations
14.
El‐Serafi, Ibrahim, Parvaneh Afsharian, Ali Moshfegh, Moustapha Hassan, & Ylva Terelius. (2015). Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation. PLoS ONE. 10(11). e0141979–e0141979. 30 indexed citations
15.
El‐Serafi, Ibrahim, Manuchehr Abedi‐Valugerdi, Parvaneh Afsharian, et al.. (2014). Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation. PLoS ONE. 9(1). e86619–e86619. 8 indexed citations
16.
Ye, Fei, Åsa Barrefelt, Heba Asem, et al.. (2014). Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging. Biomaterials. 35(12). 3885–3894. 176 indexed citations
17.
El‐Serafi, Ibrahim, et al.. (2013). Comparison of Algorithms for Oral Busulphan Area Under the Concentration–Time Curve Limited Sampling Estimate. Clinical Drug Investigation. 34(1). 43–52. 4 indexed citations
18.
Zhelev, Nikolai, et al.. (2013). From Roscovitine to CYC202 to Seliciclib – from bench to bedside: discovery and development. ZooKeys. 11 indexed citations
19.
El‐Serafi, Ibrahim, et al.. (2013). Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice. BMC Pharmacology and Toxicology. 14(1). 50–50. 7 indexed citations
20.
El‐Serafi, Ibrahim, et al.. (2012). Gas chromatographic–mass spectrometry method for the detection of busulphan and its metabolites in plasma and urine. Journal of Chromatography B. 913-914. 98–105. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qianqian Wang Breakdown of academic impact, for papers by Christian A. Fernandez Breakdown of academic impact, for papers by Chung Hee Sonn Breakdown of academic impact, for papers by Zhengsheng Liu Breakdown of academic impact, for papers by Jeong Uk Choi Breakdown of academic impact, for papers by Ping Cai Breakdown of academic impact, for papers by Wenqi Jiang Breakdown of academic impact, for papers by Kuo‐Hsiang Chuang Breakdown of academic impact, for papers by Meng Du
Rankless by CCL
2026